The following data is part of a premarket notification filed by Endoclot Plus Co., Ltd. with the FDA for Endoclot.
Device ID | K191254 |
510k Number | K191254 |
Device Name: | EndoClot |
Classification | Submucosal Injection Agent |
Applicant | EndoClot Plus Co., Ltd. 101 Room, B8 Building, 218 Xinghu Street, Suzhou Industrial Park Suzhou, CN 215000 |
Contact | Hendry Zhang |
Correspondent | Jonathan Hu Medwheat (Shanghai) Medical Technology Co., Ltd. Yangpu District Liaoyuan East Road Shuangyang First Suite No. 33 Room 303 Shanghai, CN 200093 |
Product Code | PLL |
CFR Regulation Number | 876.1500 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2019-05-10 |
Decision Date | 2020-01-30 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
26972011720216 | K191254 | 000 |
26972011720254 | K191254 | 000 |
26972011720247 | K191254 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ENDOCLOT 97292080 not registered Live/Pending |
EndoClot Plus, Inc. 2022-03-02 |
ENDOCLOT 85322084 4412920 Live/Registered |
EndoClot Plus, Inc. 2011-05-16 |